Vikki Valentine
Vikki Valentine is a senior supervising editor on NPR's science desk. She oversees the network's global health and development coverage across broadcast and digital platforms. Previously, Valentine was the network's climate change, energy, and environment editor and in this role was a recipient of a 2012 DuPont Award for coverage of natural gas drilling in Pennsylvania.
Valentine led a team that won a 2014 Peabody for its on-the-ground coverage of the largest Ebola outbreak in history: an epidemic in West Africa that spread to nearly 30,000 people. That coverage was also recognized by the Edward R. Murrow awards, a Pictures of the Year International's Award of Excellence, and by the Online News Association.
She was lead editor on the Gracie Award-winning series "#HowToRaiseAHuman" and "#15Girls." The 2018 series "#HowToRaiseAHuman" searched remote parts of the world and human evolutionary history for lost secrets to raising kids. The 2015 series "#15Girls" explored the pervasive and deadly discrimination girls in developing countries face.
Valentine won the 2009 National Academies Communication Award for the year-long multimedia project "Climate Connections." The series was also recognized by the 2008 National Academy of Sciences award, the Metcalf award for environmental journalism, the White House News Photographers Association awards, and the Webbys.
Prior to NPR, Valentine worked as a daily science news editor at Discovery.com and as a features editor and reporter at TheBaltimoreSun. Her writing has also been published by The New York Times, National Geographic, Smithsonian Channel, Marketplace, Science Magazine, andWashingtonianMagazine.
Valentine received a master's from University College London's Wellcome Trust Centre for the History of Medicine. Her bachelor's is from the University of Maryland Baltimore County.
-
Nimmu attends the Veerni boarding school in Jodhpur, India. The grade she gets on a national exam this year will decide her future. -
Tuberculosis is an ancient disease, with afflictions recorded as far back as Egypt's pharaohs. Despite effective antibiotic treatments, TB very much remains a pressing global health issue.
-
Affectionate and relatively indestructible – those historically have been key qualities of a good starter pet. Katherine Grier, author of Pets in America, talks about pets of choice over the decades, good and bad.
-
Believe it or not, some of us need to be taught how to sleep. To live up to our true sleep potential — and all the health benefits that come from a good night's rest — the sleep-troubled need to change their nighttime habits. Sleep expert Dr. Helene Emsellem answers your questions about getting a better night's rest.
-
Arthritis, bunions, knee pain and shin splints; it's a pernicious group of injuries that frequently conspires to keep runners off the road. Dr. Mark Cucuzzella and Danny Dreyer, founder of the ChiRunning method, answer your questions about how to make running work for you.
-
The Food and Drug Administration is again considering whether to allow the emergency contraception Plan B to be sold without a prescription. Here, a look at how Plan B works, and the controversy surrounding it.
-
The Bill and Melinda Gates Foundation now wields a fortune that holds the potential for dramatic change. Two public-health experts examine the attractions and perils of the Gates' role in global health. -
To learn more about data safety monitoring boards and their role in protecting patients who participate in drug studies, NPR turned to statistician David DeMets. He says the current watchdog system for patient safety is a good one, but there are practical limits on the extent to which drugs can be monitored.
-
It's allergy season and your head is pounding, what do you take? Tylenol Sinus, Advil or Imitrex? And what's a vegan with migraine to do? Johns Hopkins Neurologist David Buchholz answers your questions on migraine and its nefarious symptoms.
-
Lawmakers in Massachusetts earlier this week enacted a sweeping healthcare bill that aims to insure almost every citizen over the next three years. NPR's Richard Knox speaks with health economist Stuart Altman about the bill's attractions and weaknesses.
